Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model. (Q40723544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Effect of herpes simplex virus type-1 on growth of oral cancer in an immunocompetent, orthotopic mouse model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

lip and oral cavity carcinoma

10 November 2019

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

R M Kellman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

E J Shillitoe

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

349-356

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Multi-attenuated herpes simplex virus-1 mutant G207 exerts cytotoxicity against epithelial ovarian cancer but not normal mesothelium and is suitable for intraperitoneal oncolytic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Treatment of Experimental Intracranial Murine Melanoma with a Neuroattenuated Herpes Simplex Virus 1 Mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Effects of herpes simplex virus on human oral cancer cells, and potential use of mutant viruses in therapy of oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

A new immunocompetent murine model for oral cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Growth and histopathology of human head and neck squamous cell carcinoma implanted intraorally in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

An orthotopic floor-of-mouth cancer model allows quantification of tumor invasion

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

A murine model for the immunotherapy of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

The herpes simplex virus type 1 strain 17+ gamma 34.5 deletion mutant 1716 is avirulent in SCID mice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Herpes simplex 1716--an ICP 34.5 mutant--is severely replication restricted in human skin xenografts in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Development and application of herpes simplex virus vectors for human gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Replicative adenoviruses for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Generation of therapeutic T cells from draining lymph nodes in a murine model of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Development of a new in vivo model for head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

The role of interleukin-2 in combination adenovirus gene therapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Evaluation of ganciclovir-mediated enhancement of the antitumoral effect in oncolytic, multimutated herpes simplex virus type 1 (G207) therapy of brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Efficacy of a replication-competent adenovirus (ONYX-015) following intratumoral injection: intratumoral spread and distribution effects

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Cytokine gene transfer enhances herpes oncolytic therapy in murine squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Toxicity and neuronal infection of a HSV-1 ICP34.5 mutant in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207).

1 reference

https://api.crossref.org/works/10.1016%2FS1368-8375%2801%2900069-0

7 January 2021

10.1016/S1368-8375(01)00069-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12076698%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference